Skip to main content

Advertisement

SpringerLink
Log in

Imaging of Skeletal Involvement in Hemolymphatic Disorders

  • GERIATRICS (G GUGLIELMI, SECTION EDITOR)
  • Published:
Current Radiology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

This paper is aimed at describing the main malignant hematolymphoid disorders and their most frequent imaging appearance.

Recent Findings

Hematological malignancies are a heterogeneous group of neoplasms, including leukemia, lymphoma, and multiple myeloma that may involve the bone marrow as a primary or metastatic disease. Imaging has a pivotal role in the assessment of bone involvement, staging, and evaluation of treatment response and detection of complications.

Summary

Radiologist should be aware of most frequent findings of hematological malignant diseases, in order to perform an earlier diagnosis as well as assess an adequate clinical-therapeutic pathway.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Helms CA. Musculoskeletal MRI. Philadelphia, PA: Saunders/Elsevier; 2009.

  2. Shah LM, Hanrahan CJ. MRI of Spinal bone marrow: part 1, techniques and normal age-related appearances. Am J Roentgenol. 2011;197:1298–308. https://doi.org/10.2214/AJR.11.7005.

    Article  Google Scholar 

  3. Preisler HD. The leukemias. Dis Mon. 1994;40:525–79.

    Article  CAS  Google Scholar 

  4. Shroff GS, Truong MT, Carter BW, Benveniste MF, Kanagal-Shamanna R, Rauch G, et al. Leukemic involvement in the thorax. RadioGraphics. 2019;39:44–61. https://doi.org/10.1148/rg.2019180069.

    Article  PubMed  Google Scholar 

  5. •• Navarro SM, Matcuk GR, Patel DB, Skalski M, White EA, Tomasian A, et al. Musculoskeletal imaging findings of hematologic malignancies. RadioGraphics 2017;37:881–900. https://doi.org/10.1148/rg.2017160133. Clear and exhaustive description of most important radiological findings.

  6. Kim SH, Smith SE, Mulligan ME. Hematopoietic tumors and metastases involving bone. Radiol Clin N Am. 2011;49:1163–83. https://doi.org/10.1016/j.rcl.2011.07.004.

    Article  PubMed  Google Scholar 

  7. Parker BR, Marglin S, Castellino RA. Skeletal manifestations of leukemia, Hodgkin disease, and non-Hodgkin lymphoma. Semin Roentgenol. 1980;15:302–15. https://doi.org/10.1016/0037-198X(80)90026-7.

    Article  CAS  PubMed  Google Scholar 

  8. Tafaghodi F, Aghighi Y, Rokni Yazdi H, Shakiba M, Adibi A. Predictive plain X-ray findings in distinguishing early stage acute lymphoblastic leukemia from juvenile idiopathic arthritis. Clin Rheumatol. 2009;28:1253–8. https://doi.org/10.1007/s10067-009-1221-0.

    Article  PubMed  Google Scholar 

  9. Hwang S, Panicek DM. Magnetic resonance imaging of bone marrow in oncology, part 2. Skeletal Radiol. 2007;36:1017–27. https://doi.org/10.1007/s00256-007-0308-4.

    Article  PubMed  Google Scholar 

  10. Vande Berg BC, Lecouvet FE, Michaux L, Ferrant A, Maldague B, Malghem J. Magnetic resonance imaging of the bone marrow in hematological malignancies. Eur Radiol. 1998;8:1335–444. https://doi.org/10.1007/s003300050548.

    Article  CAS  PubMed  Google Scholar 

  11. Cao W, Liang C, Gen Y, Wang C, Zhao C, Sun L. Role of diffusion-weighted imaging for detecting bone marrow infiltration in skull in children with acute lymphoblastic leukemia. Diagn Interv Radiol. 2016;22:580–6. https://doi.org/10.5152/dir.2016.15167.

    Article  PubMed  PubMed Central  Google Scholar 

  12. • Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Döhner H, et al. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. Blood 2018;131:2745–60. https://doi.org/10.1182/blood-2017-09-806398. Exhaustive correlation between clinical, therapeutic and radiological aspects.

  13. •• Mayerhoefer ME, Archibald SJ, Messiou C, Staudenherz A, Berzaczy D, Schöder H. MRI and PET/MRI in hematologic malignancies. J Magn Reson Imaging 2020;51:1325–35. https://doi.org/10.1002/jmri.26848. Clear and exhaustive description of most important radiological findings.

  14. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96. https://doi.org/10.3322/CA.2007.0010.

    Article  PubMed  Google Scholar 

  15. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375–90. https://doi.org/10.1182/blood-2016-01-643569.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Gaudio F, Pedote P, Niccoli Asabella A, Ingravallo G, Sindaco P, Alberotanza V, et al. Bone involvement in Hodgkin’s lymphoma: clinical features and outcome. Acta Haematol. 2018;140:178–82. https://doi.org/10.1159/000490489.

    Article  PubMed  Google Scholar 

  17. Chihara D, Nastoupil LJ, Williams JN, Lee P, Koff JL, Flowers CR. New insights into the epidemiology of non-Hodgkin lymphoma and implications for therapy. Expert Rev Anticancer Ther. 2015;15:531–44. https://doi.org/10.1586/14737140.2015.1023712.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Mikhaeel NG. Primary bone lymphoma. Clin Oncol. 2012;24:366–70. https://doi.org/10.1016/j.clon.2012.02.006.

    Article  CAS  Google Scholar 

  19. Messina C, Christie D, Zucca E, Gospodarowicz M, Ferreri AJM. Primary and secondary bone lymphomas. Cancer Treat Rev. 2015;41:235–46. https://doi.org/10.1016/j.ctrv.2015.02.001.

    Article  PubMed  Google Scholar 

  20. Aye M, Cabot J, Roslly Z, Junloong C. Primary lymphoma of bone: a case report and brief review of literature. Clin Case Rep Rev. 2017. https://doi.org/10.15761/CCRR.1000346.

    Article  Google Scholar 

  21. Teagle AR, Barton H, Charles-Edwards E, Dizdarevic S, Chevassut T. Use of FDG PET/CT in identification of bone marrow involvement in diffuse large B cell lymphoma and follicular lymphoma: comparison with iliac crest bone marrow biopsy. Acta Radiol. 2017;58:1476–84. https://doi.org/10.1177/0284185117701305.

    Article  PubMed  Google Scholar 

  22. Lim CY, Ong KO. Imaging of musculoskeletal lymphoma. Cancer Imaging. 2013;13:448–57. https://doi.org/10.1102/1470-7330.2013.0036.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Krishnan A, Shirkhoda A, Tehranzadeh J, Armin AR, Irwin R, Les K. Primary bone lymphoma: radiographic–MR imaging correlation. RadioGraphics. 2003;23:1371–83. https://doi.org/10.1148/rg.236025056.

    Article  PubMed  Google Scholar 

  24. Bancroft LW. Hematopoietic tumors. Imaging of bone tumors and tumor-like lesions: techniques and applications, Berlin, Germany: Springer-Verlag; 2009, p. 351–63.

  25. Jennin F, Bousson V, Parlier C, Jomaah N, Khanine V, Laredo J-D. Bony sequestrum: a radiologic review. Skeletal Radiol. 2011;40:963–75. https://doi.org/10.1007/s00256-010-0975-4.

    Article  PubMed  Google Scholar 

  26. O’Neill J, Finlay K, Jurriaans E, Friedman L. Radiological manifestations of skeletal lymphoma. Curr Probl Diagn Radiol. 2009;38:228–36. https://doi.org/10.1067/j.cpradiol.2008.07.001.

    Article  PubMed  Google Scholar 

  27. Graham TS. The ivory vertebra sign. Radiology. 2005;235:614–5. https://doi.org/10.1148/radiol.2352021743.

    Article  PubMed  Google Scholar 

  28. Hwang S. Imaging of lymphoma of the musculoskeletal system. Radiol Clin N Am. 2008;46:379–96. https://doi.org/10.1016/j.rcl.2008.03.008.

    Article  PubMed  Google Scholar 

  29. Toledano-Massiah S, Luciani A, Itti E, Zerbib P, Vignaud A, Belhadj K, et al. Whole-body diffusion-weighted imaging in Hodgkin lymphoma and diffuse large B-cell lymphoma. RadioGraphics. 2015;35:747–64. https://doi.org/10.1148/rg.2015140145.

    Article  PubMed  Google Scholar 

  30. Ferdová E, Ferda J, Baxa J. 18 F-FDG-PET/MRI in lymphoma patients. Eur J Radiol. 2017;94:A52–63. https://doi.org/10.1016/j.ejrad.2017.01.023.

    Article  PubMed  Google Scholar 

  31. Kyle RA, Rajkumar SV. Multiple myeloma. N Engl J Med. 2004;351:1860–73. https://doi.org/10.1056/NEJMra041875.

    Article  CAS  PubMed  Google Scholar 

  32. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014: cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29. https://doi.org/10.3322/caac.21208.

    Article  PubMed  Google Scholar 

  33. National Cancer Institute. SEER Cancer Statistics Factsheets: Myeloma. Surveillance: Epidemiology, and End Results Program; 2014.

    Google Scholar 

  34. • Moreau P, San Miguel J, Sonneveld P, Mateos MV, Zamagni E, Avet-Loiseau H, et al. Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28:i52–61. https://doi.org/10.1093/annonc/mdx096. Exhaustive correlation between clinical- radiological and prognostics aspects..

  35. Nanni O, Falcini F, Buiatti E, Bucchi L, Naldoni M, Serra P, et al. Multiple myeloma and work in agriculture: results of a case-control study in Forlì. Italy Cancer Causes & Control. 1998;9:277–83. https://doi.org/10.1023/A:1008821119851.

    Article  CAS  Google Scholar 

  36. Bianchi G, Anderson KC. Understanding biology to tackle the disease: Multiple myeloma from bench to bedside, and back: clinical aspects and biology of myeloma. CA Cancer J Clin. 2014;64:422–44. https://doi.org/10.3322/caac.21252.

    Article  PubMed  Google Scholar 

  37. Durie BGM, Kyle RA, Belch A, Bensinger W, Blade J, Boccadoro M, et al. Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation. Hematol J. 2003;4:379–98.

    Article  Google Scholar 

  38. Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Dispenzieri A, et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc. 2003;78:21–33. https://doi.org/10.4065/78.1.21.

    Article  PubMed  Google Scholar 

  39. Birgegård G, Gascón P, Ludwig H. Evaluation of anaemia in patients with multiple myeloma and lymphoma: findings of the European CANCER ANAEMIA SURVEY. Eur J Haematol. 2006;77:378–86. https://doi.org/10.1111/j.1600-0609.2006.00739.x.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Moulopoulos LA, Dimopoulos MA, Weber D, Fuller L, Libshitz HI, Alexanian R. Magnetic resonance imaging in the staging of solitary plasmacytoma of bone. JCO. 1993;11:1311–5. https://doi.org/10.1200/JCO.1993.11.7.1311.

    Article  CAS  Google Scholar 

  41. Yochum TR, Rowe LJ. Yochum and Rowe’s essentials of skeletal radiology. 3rd ed. Philadelphia: Lippincott/Williams & Wilkins; 2005.

    Google Scholar 

  42. Ågren B, Löqvist B, Björkstrand B, Rudberg U, Aspelin P. Radiography and bone scintigraphy in bone marrow transplant multiple myeloma patients. Acta Radiol. 1997;38:144–50. https://doi.org/10.1080/02841859709171259.

    Article  PubMed  Google Scholar 

  43. Girish G, Finlay K, Fessell D, Pai D, Dong Q, Jamadar D. Imaging review of skeletal tumors of the pelvis malignant tumors and tumor mimics. Sci World J. 2012;2012:1–12. https://doi.org/10.1100/2012/240281.

    Article  Google Scholar 

  44. Edelstyn GA, Gillespie PJ, Grebbell FS. The radiological demonstration of osseous metastases. Exp Observ Clin Radiol. 1967;18:158–62. https://doi.org/10.1016/S0009-9260(67)80010-2.

    Article  CAS  Google Scholar 

  45. On behalf of the IMWG, Dimopoulos M, Terpos E, Comenzo RL, Tosi P, Beksac M, et al. International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma. Leukemia 2009;23:1545–56. https://doi.org/10.1038/leu.2009.89.

  46. Mahnken AH, Wildberger JE, Gehbauer G, Schmitz-Rode T, Blaum M, Fabry U, et al. Multidetector CT of the spine in multiple myeloma: comparison with MR imaging and radiography. Am J Roentgenol. 2002;178:1429–36. https://doi.org/10.2214/ajr.178.6.1781429.

    Article  CAS  Google Scholar 

  47. Healy CF, Murray JG, Eustace SJ, Madewell J, O’Gorman PJ, O’Sullivan P. Multiple myeloma: a review of imaging features and radiological techniques. Bone Marrow Res. 2011;2011:1–9. https://doi.org/10.1155/2011/583439.

    Article  Google Scholar 

  48. Horger M, Kanz L, Denecke B, Vonthein R, Pereira P, Claussen CD, et al. The benefit of using whole-body, low-dose, nonenhanced, multidetector computed tomography for follow-up and therapy response monitoring in patients with multiple myeloma. Cancer. 2007;109:1617–26. https://doi.org/10.1002/cncr.22572.

    Article  PubMed  Google Scholar 

  49. Kyle RA. Multiple myeloma: current therapy and a glimpse of the future. Scand J Haematol. 2009;35:38–47. https://doi.org/10.1111/j.1600-0609.1985.tb00797.x.

    Article  Google Scholar 

  50. Hillengass J, Usmani S, Rajkumar SV, Durie BGM, Mateos M-V, Lonial S, et al. International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders. Lancet Oncol. 2019;20:e302–e312312. https://doi.org/10.1016/S1470-2045(19)30309-2.

    Article  PubMed  Google Scholar 

  51. Dimopoulos MA, Hillengass J, Usmani S, Zamagni E, Lentzsch S, Davies FE, et al. Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement. JCO. 2015;33:657–64. https://doi.org/10.1200/JCO.2014.57.9961.

    Article  Google Scholar 

  52. Dimopoulos LA, Moulopoulos IMA. Imaging of myeloma bone disease: implications for staging, prognosis and follow-up. Acta Oncol. 2000;39:823–7. https://doi.org/10.1080/028418600750063578.

    Article  CAS  PubMed  Google Scholar 

  53. Lecouvet FE, Vande Berg BC, Malghem J, Maldague BE. Magnetic resonance and computed tomography imaging in multiple myeloma. Semin Musculoskelet Radiol. 2001;05:043–56. https://doi.org/10.1055/s-2001-12920.

    Article  CAS  Google Scholar 

  54. Pawlyn C, Fowkes L, Otero S, Jones JR, Boyd KD, Davies FE, et al. Whole-body diffusion-weighted MRI: a new gold standard for assessing disease burden in patients with multiple myeloma? Leukemia. 2016;30:1446–8. https://doi.org/10.1038/leu.2015.338.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Messiou C, Kaiser M. Whole body diffusion weighted MRI : a new view of myeloma. Br J Haematol. 2015;171:29–37. https://doi.org/10.1111/bjh.13509.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Ferraro R, Agarwal A, Martin-Macintosh EL, Peller PJ, Subramaniam RM. MR imaging and PET/CT in diagnosis and management of multiple myeloma. RadioGraphics. 2015;35:438–54. https://doi.org/10.1148/rg.352140112.

    Article  PubMed  Google Scholar 

  57. Husband JES, Reznek RH, editors. Imaging in oncology: in 2 vol. Oxford: Isis Medical Media; 1998.

    Google Scholar 

  58. Woo E, Yu YL, Ng M, Huang CY, Todd D. Spinal cord compression in multiple myeloma: who gets it? Aust N Z J Med. 1986;16:671–5. https://doi.org/10.1111/j.1445-5994.1986.tb00010.x.

    Article  CAS  PubMed  Google Scholar 

  59. Loughrey GJ, Collins CD, Todd SM, Brown NM, Johnson RJ. Magnetic resonance imaging in the management of suspected spinal canal disease in patients with known malignancy. Clin Radiol. 2000;55:849–55. https://doi.org/10.1053/crad.2000.0547.

    Article  CAS  PubMed  Google Scholar 

  60. • Weltgesundheitsorganisation. WHO classification of tumours of haematopoietic and lymphoid tissues. Revised 4th edition. Lyon: International Agency for Research on Cancer; 2017. Exhaustive correlation between clinical- radiological and prognostics aspects.

  61. • Pardanani A. Systemic mastocytosis in adults: 2019 update on diagnosis, risk stratification and management. Am J Hematol 2018:ajh.25371. https://doi.org/10.1002/ajh.25371. Exhaustive correlation between clinical- radiological and prognostics aspects.

  62. Delsignore JL, Dvoretsky PM, Hicks DG, O’Keefe RJ, Rosier RN. Mastocytosis presenting as a skeletal disorder. Iowa Orthop J. 1996;16:126–34.

    CAS  PubMed  PubMed Central  Google Scholar 

  63. Seitz S, Barvencik F, Koehne T, Priemel M, Pogoda P, Semler J, et al. Increased osteoblast and osteoclast indices in individuals with systemic mastocytosis. Osteoporos Int. 2013;24:2325–34. https://doi.org/10.1007/s00198-013-2305-x.

    Article  CAS  PubMed  Google Scholar 

  64. Fritz J, Fishman EK, Carrino JA, Horger MS. Advanced imaging of skeletal manifestations of systemic mastocytosis. Skeletal Radiol. 2012;41:887–97. https://doi.org/10.1007/s00256-012-1374-9.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Diagnostic Imaging 2, AOU Sassari, Sassari, Italy

    Paola Crivelli

  2. Department of Radiology, University of Trieste, Trieste, Italy

    Elisa Baratella

  3. Department of Clinical and Experimental Medicine, Institute of Diagnostic Imaging 2, University of Sassari, Sassari, Italy

    Stefano Zedda & Maurizio Conti

  4. Department of Medicine, Surgery and Health Science, University of Trieste, Trieste, Italy

    Cristina Marrocchio

  5. Department of Radiology, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), Strada di Fiume 447, Trieste, Italy

    Maria Assunta Cova

Authors
  1. Paola Crivelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elisa Baratella
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stefano Zedda
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Cristina Marrocchio
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Maria Assunta Cova
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Maurizio Conti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paola Crivelli.

Ethics declarations

Conflicts of interest

The Authors declare that they have no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Geriatrics.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Crivelli, P., Baratella, E., Zedda, S. et al. Imaging of Skeletal Involvement in Hemolymphatic Disorders. Curr Radiol Rep 8, 18 (2020). https://doi.org/10.1007/s40134-020-00361-3

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s40134-020-00361-3

Keywords

Search

Navigation